Stage IVA Rectal Cancer AJCC v7

7 clinical trials · Condition

Record	Firm	Date
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer (NCT03300544)	National Cancer Institute (NCI)	2019-05-14
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery (NCT03317119)	City of Hope Medical Center	2018-04-11
TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery (NCT03297710)	Mayo Clinic	2017-12-11
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882)	SWOG Cancer Research Network	2017-11-27
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561)	National Cancer Institute (NCI)	2016-02-01
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)	National Cancer Institute (NCI)	2011-02-10
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer (NCT00068692)	National Cancer Institute (NCI)	2003-10-15

Every clearance here is in the API, with alerts when new ones post.